Shenqi Yishen Granules

Shenqi Yishen Granules is a Traditional Chinese Medicine (TCM) compound formulation primarily investigated for the treatment of IgA nephropathy (IgAN) and chronic kidney disease (CKD). The formulation is typically used to address 'Qi and Yin deficiency,' a common pattern in TCM diagnosis for renal patients. It is designed to reduce 24-hour urinary protein quantification and preserve renal function. Clinical evaluation, such as the studies led by Keda Lu, often focuses on its efficacy and safety when used as an adjunct to standard-of-care treatments like irbesartan (an angiotensin II receptor blocker) in Asian adult populations with CKD stages 1-2.

Brand names

Shenqi Yishen Granules

Other names

Shenqi Yishen Keli